VERNIERI, CLAUDIO

VERNIERI, CLAUDIO  

Dipartimento di Oncologia ed Emato-Oncologia  

Mostra records
Risultati 1 - 20 di 37 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Real-world progression-free survival 2 with CDK4/6 inhibitors plus endocrine therapy and subsequent line: Results from the multicenter SISTER study 2023 Corti, C.Sposetti, C.Boldrini, L.Vernieri, C.Curigliano, G.Criscitiello, C. + Article (author) -
Platinum-based chemotherapy and PARP inhibitors for patients with a germline BRCA pathogenic variant and advanced breast cancer (LATER-BC): retrospective multicentric analysis of post-progression treatments 2023 Valenza, CarmineTrapani, DarioSposetti, CaterinaBoscolo Bielo, LucaMarra, AntonioVernieri, ClaudioCurigliano, Giuseppe + Article (author) -
The impact of COVID-19 on diagnosis of recurrent breast cancer 2022 Depretto, CatherineBaili, Paolode Braud, Filippo G.Vernieri, ClaudioVingiani, AndreaPruneri, Giancarlo + Article (author) -
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin 2022 Zattarin, EmmaNichetti, FedericoLigorio, FrancescaMazzeo, LauraLobefaro, RiccardoFuca, GiovanniPeverelli, GiorgiaVingiani, Andreade Braud, FilippoVernieri, Claudio + Article (author) -
PillarX: A Microfluidic Device to Profile Circulating Tumor Cell Clusters Based on Geometry, Deformability, and Epithelial State 2022 Fardin, AmirGiangreco, GiovanniMarchesi, StefanoVernieri, ClaudioLobefaro, RiccardoSigismund, SaraFiore, Pier Paolo DiScita, Giorgio + Article (author) -
Predictive role of CD36 expression in HER2-positive breast cancer patients receiving neoadjuvant trastuzumab 2022 Ligorio, FrancescaVerderio, PaoloCiniselli, Chiara MauraCorsetto, Paola AntoniaLorenzini, DanieleVingiani, AndreaPruneri, GiancarloVernieri, Claudio + Article (author) -
Aromatase Inhibitors in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer: Profiles of Psychological Symptoms and Quality of Life in Different Patient Clusters 2021 Infante, G.Vernieri, C. + Article (author) -
Endosomal trafficking and DNA damage checkpoint kinases dictate survival to replication stress by regulating amino acid uptake and protein synthesis 2021 Ajazi A.Manfrini N.Biffo S.Minucci S.Vernieri C.Foiani M. + Article (author) -
Impact of baseline and on-treatment glycemia on everolimus-exemestane efficacy in patients with hormone receptor-positive advanced breast cancer (EVERMET) 2021 Vernieri, ClaudioNichetti, FedericoMarra, AntonioRandon, GiovanniLigorio, FrancescaFerraro, EmanuelaTrapani, DarioMilani, AndreaBernocchi, OttaviaAjazi, ArtaGenerali, DanieleLosurdo, AgneseCurigliano, GiuseppePruneri, GiancarloMariani, Luigide Braud, Filippo + Article (author) -
Prognostic role of body mass index (BMI) in patients with Human Epidermal growth factor Receptor 2 (HER2)epositive early breast cancer treated with adjuvant trastuzumab-containing chemotherapy 2020 Ligorio, F.Zambelli, L.Bottiglieri, A.Castagnoli, L.Zattarin, E.Vingiani, A.Pruneri, G.de Braud, F.Vernieri, C. + Article (author) -
Berberine in the treatment of metabolism-related chronic diseases: A drug cloud (dCloud) effect to target multifactorial disorders 2020 Vernieri C.Foiani M. + Article (author) -
Association between the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios and efficacy of CDK 4/6 inhibitors in advanced breast cancer: The observational multicenter Italian PALMARES study 2020 Zattarin, EFabbroni, CLigorio, FCorti, CBernocchi, OSirico, MCurigliano, GDe Braud, FGMVernieri, C + Article (author) -
Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications 2020 Zattarin, ELeporati, RLigorio, FLobefaro, RVingiani, APruneri, GVernieri, C Article (author) -
Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers 2020 Di Tano M.Vernieri C.Fanti M.Curigliano G.Nencioni A.de Braud F. + Article (author) -
Combination of baseline LDH, performance status and age as integrated algorithm to identify solid tumor patients with higher probability of response to anti PD-1 and PD-l1 monoclonal antibodies 2019 Randon G.Vernieri C.de Braud F. + Article (author) -
Weighing the prognostic role of hyponatremia in hospitalized patients with metastatic solid tumors: the HYPNOSIS study 2019 Fucà GMariani LGalli GDi Nicola MVernieri CDotti KPietrantonio Fde Braud F + Article (author) -
Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer : a Retrospective Comparison of Efficacy and Safety Profiles 2019 Vernieri, ClaudioPrisciandaro, MicheleMaggi, ClaudiaMennitto, AlessiaFabbroni, ChiaraFarè, Elenade Braud, Filippo + Article (author) -
Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives 2019 Vernieri, ClaudioMennitto, AlessiaMaggi, ClaudiaPrisciandaro, MicheleFabbroni, Chiarade Braud, Filippo + Article (author) -
Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs) 2019 C. VernieriS. PuscedduG. FucàG. CentonzeL. CastagnoliE. FerrariA. AjaziM. FoianIV. MazzaferroG. PruneriF. de Braud + Article (author) -
Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma : the FAME Trial 2019 Vernieri, ClaudioGalli, GiuliaRizzo, Angela MariaCorsetto, Paola AntoniaPruneri, Giancarlode Braud, Filippo + Article (author) -